Drug Trial Radar · NCT07157033
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Jan 1, 2026
Primary completion
Jul 31, 2029
Study completion Jul 31, 2034
Sponsor
- Lead sponsor
- Xerient PharmaIndustry
- Sponsor type
- Industry
- First posted
- Sep 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.
Conditions
- Locally Advanced Pancreatic Adenocarcinoma
- Locally Advanced Pancreas Cancer
- Locally Advanced Pancreatic Ductal Adenocarcinoma
Interventions
XER-001Drug
XER-001 (Amifostine for nasoduodenal delivery)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety Assessments [Dose Escalation]Time frame: 18 Months
- Safety Assessments [Dose Escalation]Time frame: 18 Months
- Safety Assessments [Dose escalation and Dose Expansion]Time frame: 40 months
- Safety Assessments [Dose Escalation and Dose Expansion]Time frame: 40 Months
- Safety Assessments [Dose Escalation and Dose Expansion]Time frame: 40 Months
- Safety Assessments [Dose Escalation and Dose Expansion]Time frame: 40 Months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
City of Hope
Duarte, California · Recruiting
CIty of Hope
Irvine, California · Recruiting
Karmanos Cancer Institute
Detroit, Michigan · Recruiting
Christus St. Vincent Regional Cancer Center
Santa Fe, New Mexico · Recruiting
Oncology Consultants, P.A.
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.